Stay updated on High-Risk Myeloma Combo Therapy Clinical Trial

Sign up to get notified when there's something new on the High-Risk Myeloma Combo Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the High-Risk Myeloma Combo Therapy Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-01T06:00:24.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T16:34:10.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from 2025-03-25 to 2024-12-16.
    Difference
    1%
    Check dated 2025-04-09T10:59:46.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T22:01:29.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T14:41:13.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T10:17:48.000Z thumbnail image

Stay in the know with updates to High-Risk Myeloma Combo Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the High-Risk Myeloma Combo Therapy Clinical Trial page.